Neo Ivy Capital Management - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 175 filers reported holding PTC THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,245
+371.6%
40,708
+245.0%
0.24%
+110.3%
Q3 2023$264
+1289.5%
11,800
+2437.6%
0.12%
+1060.0%
Q2 2023$19
-91.9%
465
-92.4%
0.01%
-93.7%
Q4 2022$234
-99.8%
6,132
+106.5%
0.16%
-50.0%
Q2 2022$118,000
+76.1%
2,969
+124.9%
0.32%
+310.4%
Q3 2021$67,000
-94.4%
1,320
-95.0%
0.08%
-83.0%
Q2 2020$1,197,000
+2502.2%
26,434
+2471.4%
0.45%
+502.7%
Q1 2020$46,000
-40.3%
1,028
-36.3%
0.08%
-15.7%
Q4 2019$77,000
-93.2%
1,613
-93.6%
0.09%
-86.0%
Q2 2019$1,130,00025,1140.64%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 110,794$3,802,00010.50%
Boxer Capital, LLC 2,155,000$73,960,0009.14%
RTW INVESTMENTS, LP 1,922,346$65,975,0006.14%
GREAT POINT PARTNERS LLC 1,225,000$42,042,0005.31%
Opaleye Management Inc. 190,000$6,520,0002.43%
SCOPIA CAPITAL MANAGEMENT LP 1,626,965$55,837,0001.89%
SPHERA FUNDS MANAGEMENT LTD. 345,500$11,858,0001.34%
SECTORAL ASSET MANAGEMENT INC 233,536$8,015,0001.09%
Elk Creek Partners, LLC 377,674$12,962,0001.08%
Orbimed Advisors 1,519,700$52,156,0000.96%
View complete list of PTC THERAPEUTICS INC shareholders